MicroRNA let-7家族与肿瘤的研究进展.pdfVIP

现代肿瘤医学 2015年 2月 第 23卷第 4期 MODERNONCOLOGY，Feb．2015，V0L23，NO．04 · 571 · — 2983． 2007．28：742一762． [11] KnanfJA，KurodaH，BasuS，eta1．RET／PTC—induceddediffer- [18] LeeJH，LeeES，Kim YS．Clinic0path0JogicsingificnaceofBRAF entiationofthyroid cellsismediated through Y1062 signaling V600E mutationinpapillarycracinomasofthethyroid：A meta— throughSHC—RAS—MAPkinase[J]．Oncogene，2003，22 analysis[J]．Cancer，2007，110(1)：38—40． (28)：4406—4412． [19] EliseiR，UgoliniC，ViolaD，eta1．BRAFV600Emutationnadout- [12] FukahofiM，YoshidaA，HayashiH，eta1．Theassociationsbe— comeofpatientswithpapillarythyroidcarcinoma：A 15一yera me— tweenRASmutationsandclinicalcharacteristicsinfollicularthy— dianfollow—upstudy[J]．JClinEndoerinolMeta1)，2008．93 midtumor$：New insightsrfom asinglecenterandalargepatient (10)：3943—3949． eoho~[J]．Thyroid，2012，22(7)：683—689． [2O] XingM．BRAFmutationinthyroidcancer[J]．EndocrRelat [13] EloyC，SantosJ，ScaresP，eta1．Thepreeminenceofgrowthpat— Cancer，2005，12：245— 262． ternandinvasivenessnadthelimitedinfluenceofBRAFandRAS [21] SantarpiaL，ShermanSI，MraabottiA，eta1．Detectionna dmoleeu- mutationsintheoccu／Tenceofpapillarythyroidcarcinomalymph lra characterizationofanovelBRAFactivateddomainmutationin nodemetastases[J]．VirchowsArch，2011，459(3)：265—276． follicularvariantofpapillarythyroidcarcinoma[J]．HumPathol， [14] O NeillcJ，BullockM，ChouA，eta1．BRAF(V60OE)mutationis 2009，40(6)：827—833． associatedwithai1increasedriskofnodal recurrencerequiringre— [22] KebebewE，WengJ，BauerJ，eta1．Th eprevalencenadprongostic operativesurgeryinpatientswithpapillarythyroidcancer[J]． valueofBRAFmutationi